GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Cash Flow from Discontinued Operations

Galapagos NV (WBO:GLPG) Cash Flow from Discontinued Operations : €0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Galapagos NV Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Galapagos NV's cash flow from discontinued operations for the three months ended in Sep. 2024 was €0.0 Mil. It means Galapagos NV received €0.0 Mil from the sale of part of business quarterly. Galapagos NV's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2024 was €0.0 Mil.


Galapagos NV Cash Flow from Discontinued Operations Historical Data

The historical data trend for Galapagos NV's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Cash Flow from Discontinued Operations Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Galapagos NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Galapagos NV Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galapagos NV Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Galapagos NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Cash Flow from Discontinued Operations
Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Galapagos NV Headlines

From GuruFocus

EcoR1 Capital, LLC Increases Stake in Galapagos NV

By GuruFocus News 10-08-2024

Full Year 2022 Galapagos NV Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2023 Galapagos NV Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q4 2021 Galapagos NV Earnings Call Transcript

By GuruFocus Research 02-07-2024

Half Year 2023 Galapagos NV Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q2 2021 Galapagos NV Earnings Call Transcript

By GuruFocus Research 02-07-2024

Half Year 2022 Galapagos NV Earnings Call Transcript

By GuruFocus Research 02-07-2024

Galapagos NV at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-07-2024